Novelix Pharmaceuticals Ltd Closes Trading Window for Designated Persons

Key Highlights

• Novelix Pharmaceuticals Ltd has closed the trading window for designated persons and their relatives.
• The closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading.
• The trading window will remain closed from April 01, 2026, till 48 hours after the declaration of Audited Financial Results for the quarter ending on March 31, 2026.
• The date of consideration of the Financial Results will be intimated in due course.
• Designated persons, their relatives, and other insiders under the PIT Regulations are directed not to trade in the securities of the Company during the aforesaid trading window closure period.